Alto Neuroscience, Inc. (ANRO) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Alto Neuroscience, Inc. (ANRO) Earnings Overview
As of June 13, 2026, Alto Neuroscience, Inc. (ANRO) reported trailing twelve-month net income of -$74M, reflecting +12.4% year-over-year growth. The company earned $-2.26 per diluted share over the past four quarters.
Looking at the long-term picture, ANRO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2021.
Alto Neuroscience, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), NRXP (-$25M net income, -2336.5% margin), INVA ($504M net income, 63.8% margin), ANRO has comparable earnings metrics. Compare ANRO vs SAVA →
ANRO Earnings vs Peers
Earnings metrics vs comparable public companies
ANRO Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$63M | -2.9% | -$66M | $-2.19 | - | - |
| 2024 | -$61M | -69.2% | -$69M | $-2.50 | - | - |
| 2023 | -$36M | -31.0% | -$38M | $-1.35 | - | - |
| 2022 | -$28M | -201.6% | -$29M | $-1.08 | - | - |
| 2021 | -$9M | - | -$12M | $-0.36 | -4374.8% | -5741.0% |
Download Data
Export ANRO earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in ANRO back in 2021?
Total return with dividends reinvested · 5+ years of data
Calculate ReturnsHow much would $100/month in ANRO be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs ANRO Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationANRO vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowANRO — Frequently Asked Questions
Quick answers to the most common questions about buying ANRO stock.
What is ANRO earnings per share (EPS)?
ANRO trailing twelve-month (TTM) diluted EPS is $-2.26, reflecting +12.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Alto Neuroscience, Inc.'s net income?
Alto Neuroscience, Inc. (ANRO) trailing twelve-month net income is $-74M as of 2025. Earnings grew +12.4% year-over-year.
Is ANRO profitable?
ANRO is not currently profitable on a TTM basis, reporting a net loss of $-74M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ANRO's earnings growth rate?
ANRO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are ANRO's profit margins?
Alto Neuroscience, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -41.8%.
Is ANRO growing earnings?
ANRO is growing earnings steadily. YoY EPS growth of +12.4% is consistent with the 5-year CAGR of N/A. TTM net income is $-74M.
What was ANRO's best earnings year?
Alto Neuroscience, Inc.'s highest annual net income on record is $-9M, achieved in fiscal year 2021. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were ANRO's earnings last quarter?
ANRO's most recent reported quarter was Q1 2026. Net income was $-26M with diluted EPS of $-0.80. For a full breakdown of all quarters, see the quarterly earnings table on this page.